Armata Pharmaceuticals shares have added about 27.6% since the beginning of the year versus the S&P 500's gain of 8.4%. What's Next for Armata Pharmaceuticals? Armata Pharmaceuticals, Inc. (ARMP) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of$0.39. This compares to a loss of $0.65 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +17.95%. A quarter ago, it was expected that t ...